Research Protocol

 
News Articles for Research Protocol top ^
Overall Response Rate (ORR) to be the Primary Endpoint to Support Accelerated Approval with Progression-Free Survival (PFS) to Support Full Approval Safety and Efficacy Data from Over 30 CLL Patients from the On-going Phase 2 Trial of the Combination of TG-1101 plus ibrutinib Anticipated to be Presented at ASH 2014 NEW YORK, Sept.
Sign-up for TG Therapeutics Announces Special Protocol Assessment (SPA) Agreement With the FDA for Its First Phase 3 Clinical Trial of TG-1101 (ublituximab) in Combination With Imbruvica(R) (ibrutinib) for Patients With Previously Treated Chronic Lymphocytic Leukemia investment picks
Highlights: - Multi-protocol DDR4/LPDDR4 controller and PHY IP solution enables designers to make performance and system cost tradeoffs while reducing risk and shortening design cycles - Combined high-performance and low-power multi-protocol DDR IP provides flexibility to address emerging memory and system cost requirements in consumer, mobile and enterprise applications - Extends memory leadership from LPDDR3/DDR4/3 to include LPDDR4 with performance up to 3200Mbps SAN JOSE, Calif.
Sign-up for Cadence Announces Industry's First Multi-Protocol DDR4 and LPDDR4 IP Solution investment picks
Pivotal Phase 3 Clinical Trial Targeted to Begin in First Half of 2015 PRINCETON, N.J. , Sept.
Sign-up for Soligenix Announces FDA Clearance of Phase 3 Clinical Protocol of SGX301 in Cutaneous T-Cell Lymphoma investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1148929&ProfileId=051205&sourceType=1 ATLANTA, GA --
Sign-up for Dutch Gold Develops Neuroprotective Protocols for Athletic Concussion Treatment investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1149530&ProfileId=051205&sourceType=1 SAN DIEGO, CA --
Sign-up for Regen BioPharma Submits Experimental Protocol to FDA for HemaXellerate Aplastic Anemia Trial investment picks
IP Prototyping Kits Enable Designers to Accelerate Prototyping, Software Development and Integration of IP into SoCs MOUNTAIN VIEW, Calif.
Sign-up for Synopsys Expands IP Accelerated Initiative with New DesignWare IP Prototyping Kits for 10 Interface Protocols investment picks

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Research Protocol
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Research Proposals  |  Next: Research Providers